AAOS 2022: Opioid-Sparing Pain Management Protocol After Shoulder Arthroplasty .
Opioid-Sparing Pain Management Protocol following Shoulder Arthroplasty Results in Less Opioid Consumption and Higher Satisfaction: A Prospective, Randomized Control Trial
A total of 78 patients were included in this randomized trial comparing an opioid-sparing and opioid-based pain protocol for pain management after total shoulder arthroplasty. Outcomes of interest included pain scores, opioid consumption, patient satisfaction, range of motion, patient-reported functional outcomes, complications, readmission and reoperation. Results revealed significantly lower opioid consumption up to 12 weeks post-operation, and higher patient satisfaction with pain management up to 6 weeks post-operation, in the opioid-sparing group. No differences in pain scores, range of motion, functional outcomes, complications, readmissions or reoperations were observed.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
